scispace - formally typeset
Journal ArticleDOI

Specific chemotherapy of Chagas disease: relevance, current limitations and new approaches.

Julio A. Urbina
- 01 Jul 2010 - 
- Vol. 115, Iss: 1, pp 55-68
Reads0
Chats0
TLDR
A critical review of the development of specific chemotherapeutic approaches for the management of American Trypanosomiasis or Chagas disease is presented, and the most promising approaches are ergosterol biosynthesis inhibitors such as posaconazole and ravuconazole.
About
This article is published in Acta Tropica.The article was published on 2010-07-01. It has received 402 citations till now. The article focuses on the topics: Benznidazole & Nifurtimox.

read more

Citations
More filters
Journal ArticleDOI

Randomized trial of posaconazole and benznidazole for chronic Chagas' disease.

TL;DR: Posaconazole showed antitrypanosomal activity in patients with chronic Chagas' disease, however, significantly more patients in the posaconazoles groups than in the benznidazole group had treatment failure during follow-up.
Book ChapterDOI

Inhibition of Cytochrome P450 Enzymes

TL;DR: Cytochrome P450s (P450s) are subject to inhibition/inactivation by various chemically diverse agents, which may interact directly or indirectly with either the P450 prosthetic heme or the protein moiety or with both moieties.
Journal ArticleDOI

Trypanosoma cruzi genetic diversity: Something new for something known about Chagas disease manifestations, serodiagnosis and drug sensitivity.

TL;DR: The interplay between parasite and host genetics should have an important role in the definition of Chagas disease pathogenesis, anti-T.
Journal ArticleDOI

Antitrypanosomal Therapy for Chronic Chagas' Disease

TL;DR: A 42-year-old woman presents after donating blood and receiving a report that she is positive for Chagas' disease.
References
More filters
Journal Article

Heart-lung transplantation.

TL;DR: A broad overview of the various grounds upon which this difference is likely based and discuss recent advances in each area: 1) criteria for the selection of candidates and donors, 2) methods for ex-vivo preservation of donor organs, 3) technical execution of the operative procedure, and 4) prevention of postoperative infection as discussed by the authors.
Journal ArticleDOI

Therapeutic approaches to bone diseases.

TL;DR: A better understanding of the biology of osteoclasts and osteoblasts is providing opportunities for developing therapeutics to treat diseases of bone, and promoting bone formation with growth factors or hormones is an approach that would be a valuable adjunct therapy for patients receiving inhibitors of bone resorption.
Journal ArticleDOI

The Genome of the African Trypanosome Trypanosoma brucei

Matthew Berriman, +104 more
- 15 Jul 2005 - 
TL;DR: Comparisons of the cytoskeleton and endocytic trafficking systems of Trypanosoma brucei with those of humans and other eukaryotic organisms reveal major differences.
Journal ArticleDOI

The genome of the kinetoplastid parasite, Leishmania major.

Alasdair Ivens, +103 more
- 15 Jul 2005 - 
TL;DR: The organization of protein-coding genes into long, strand-specific, polycistronic clusters and lack of general transcription factors in the L. major, Trypanosoma brucei, and Tritryp genomes suggest that the mechanisms regulating RNA polymerase II–directed transcription are distinct from those operating in other eukaryotes, although the trypanosomatids appear capable of chromatin remodeling.
Journal ArticleDOI

The genome sequence of Trypanosoma cruzi, etiologic agent of Chagas disease

Najib M. El-Sayed, +85 more
- 15 Jul 2005 - 
TL;DR: Although the Tritryp lack several classes of signaling molecules, their kinomes contain a large and diverse set of protein kinases and phosphatases; their size and diversity imply previously unknown interactions and regulatory processes, which may be targets for intervention.
Related Papers (5)